The effects of concurrent oral paliperidone or risperidone use with paliperidone long-acting injection

Introduction: Dosing recommendations for paliperidone long-acting injectable antipsychotic (LAIA) do not include oral antipsychotic (OAP) overlap; however, OAPs are often given concurrently despite limited evidence describing both the risks and benefits of this practice. Methods: A retrospective cha...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Trevor A. Stump, PharmD, BCPP, Leigh Anne Nelson, PharmD, BCPP, Yifei Liu, BS Pharm, PhD, Carrie R. Kriz, MS, Courtney A. Iuppa, PharmD, BCPP, Lauren A. Diefenderfer, PharmD, BCPP, Shelby E. Lang, PharmD, BCPP, Ellie S. R. Elliot, PharmD, BCPP, Roger W. Sommi, PharmD, BCPP, FCCP
Format:	Artigo
Sprog:	Inglês
Udgivet:	American Association of Psychiatric Pharmacists 2021-01-01
Serier:	Mental Health Clinician
Fag:	paliperidone palmitate long-acting injectable antipsychotic oral antipsychotic overlap benztropine adverse events decompensation
Online adgang:	https://theijpt.org/doi/pdf/10.9740/mhc.2021.01.012
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!